Dermata Therapeutics prices ~$18M IPO

Clinical-stage dermatology company Dermata Therapeutics (DRMA) priced its upsized initial public offering (IPO) of 2,571,428 shares of its common stock and accompanying warrants to purchase up to 2,571,428 shares of common stock.